In vivo studies showed that high levels of PRL accelerated the emergence of spontaneous mammary tumors [6] and could act as an anti-cytotoxic factor in breast cancer cells, contributing to drug resistance [7]. This evidence concerns the gene PRL and breast carcinoma.